Chao, B. H., Harrison, M. R., Kolesar, J., Vanderhoek, M., Perlman, S., Eickhoff, J. C., … Liu, G. (2011). Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal. Journal of Clinical Oncology, 29(15_suppl), e13556–e13556. https://doi.org/10.1200/jco.2011.29.15_suppl.e13556

Chao, B. H., M. R. Harrison, J. Kolesar, M. Vanderhoek, S. Perlman, J. C. Eickhoff, L. Carmichael, et al. “Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal.” Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): e13556–e13556. https://doi.org/10.1200/jco.2011.29.15_suppl.e13556.

Chao BH, Harrison MR, Kolesar J, Vanderhoek M, Perlman S, Eickhoff JC, et al. Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal. Journal of Clinical Oncology. 2011 May 20;29(15_suppl):e13556–e13556.

Chao, B. H., et al. “Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal.” Journal of Clinical Oncology, vol. 29, no. 15_suppl, American Society of Clinical Oncology (ASCO), May 2011, pp. e13556–e13556. Crossref, doi:10.1200/jco.2011.29.15_suppl.e13556.

Chao BH, Harrison MR, Kolesar J, Vanderhoek M, Perlman S, Eickhoff JC, Carmichael L, Alberti DB, Wilding G, Jeraj R, Liu G. Pharmacodynamic and pharmacokinetic characterization of tumor proliferation during acute sunitinib (SU) withdrawal. Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2011 May 20;29(15_suppl):e13556–e13556.